Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

NKTRNKTR

Showing 4 of 13 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in NEKTAR THERAPEUTICS

As of its Q1 2025 13F, Goldman Sachs Group held 531,362 shares of NKTR (Nektar Therapeutics), worth $361,326. Goldman Sachs Group's 13F filings listed NKTR from Q2 2022 to Q1 2025, 12 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.3M

Total Shares Change

-1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$25.84
0
2025-Q1
Decreased
531,362
-26.9%
$361,3260.0%$10.20
0
2024-Q4
Decreased
727,386
-59.2%
$676,4690.0%$13.95
0
2024-Q3
Increased
1.8M
+0.9%
$2.3M0.0%$19.50
26

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used